On June 23, 2025, Avalon GloboCare Corp. signed an agreement to co-develop a THC breathalyzer with Qi Diagnostics, involving milestone payments totaling $1,050,000 to be paid over various phases of the project. This filing is part of strategic plans to expand into cannabis-related technology and is significant for the company.